PhD, Biochemistry, Rush University Medical Center, Chicago, IL
MBA, University of Notre Dame, Notre Dame, IN
Brian Pfister, PhD, MBA
Dr. Brian Pfister has more than 20 years of experience in leading early-stage corporate strategy and non-dilutive funding efforts in various life science sectors. He provides expertise in federal R&D and advanced development programs as well as corporate funding strategy to the Conafay Group.
For more than four and a half years, Dr. Pfister managed the future strategy and programming of federal funding in regenerative medicine for the Department of Defense within the Clinical and Rehabilitative Medicine Research Program (CRMRP) / Joint Program Committee-8 at the U.S. Army Medical Research and Development Command (MRDC). His federal research portfolio included the Armed Forces Institute of Regenerative Medicine (AFIRM) and congressionally directed research programs such as the Peer Reviewed Restorative Transplantation Research (RTR) Program.
Before working with the U.S. Army, Dr. Pfister was the chief executive officer of Articular Engineering, a private biotechnology company focused on the development of cellular therapeutics for the orthopedic market. In this capacity, he led the development of program success metrics, resource-based analysis, business plan and business case development, market research, budgets, valuation model development and capital-raising efforts. He established a service-based business unit that partnered with pharmaceutical and biotech clients during preclinical research and development efforts. He has also served as the technical director for a quality and safety testing laboratory serving the food and nutraceutical industry.
Dr. Pfister ran track and cross country throughout college and remains an avid cyclist and ultra-distance runner, competing in numerous events each year. He received a doctorate in biochemistry from Rush University Medical Center in Chicago and a Master of Business Administration from The University of Notre Dame.